Literature DB >> 8065520

Differential adenoassociated virus vector-driven expression of a neuropeptide Y gene in primary rat brain astroglial cultures after transfection with Sendai virosomes versus Lipofectin.

C M de Fiebre1, P Wu, D Notabartolo, W J Millard, E M Meyer.   

Abstract

The ability of Sendai virosomes or Lipofectin to introduce an AAV vector into primary rat brain astroglial cultures was characterized. The pJDT95npy vector was constructed by inserting rat NPY cDNA downstream from the indigenous AAV p5, p19 and p40 promoters in pJDT95. Lipofectin-mediated transfection with pJDT95npy (10 micrograms) resulted in pronounced expression of several NPY mRNA species: p5-driven (3.3 kb), p19-driven (2.7 kb) and p40-driven (0.6, 0.8, 1.1, and 1.8 kb). Exposure to virosomally encapsulated pJDT95npy (50 or 100 ng) resulted in transient expression of some p40-driven mRNA species (0.8 and 1.8 kb). Neither method produced astroglia cells which synthesized mature NPY immunoreactivity. This demonstrates that an AAV-derived vector can drive gene expression in astroglia, that Sendai virosomes can infuse vectors into astroglia, but that the amount of DNA infused in this manner may limit long term expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8065520     DOI: 10.1007/bf00967701

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  30 in total

Review 1.  Parvovirus replication.

Authors:  K I Berns
Journal:  Microbiol Rev       Date:  1990-09

2.  Construction and replication of an adeno-associated virus expression vector that contains human beta-globin cDNA.

Authors:  S Ohi; M Dixit; M K Tillery; S G Plonk
Journal:  Gene       Date:  1990-05-14       Impact factor: 3.688

3.  The improved efficient method for introducing macromolecules into cells using HVJ (Sendai virus) liposomes with gangliosides.

Authors:  Y Kaneda; T Uchida; J Kim; M Ishiura; Y Okada
Journal:  Exp Cell Res       Date:  1987-11       Impact factor: 3.905

4.  Positive and negative autoregulation of the adeno-associated virus type 2 genome.

Authors:  M A Labow; P L Hermonat; K I Berns
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

5.  Adeno-associated virus: a vector system for efficient introduction and integration of DNA into a variety of mammalian cell types.

Authors:  J S Lebkowski; M M McNally; T B Okarma; L B Lerch
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

6.  Modulation of neuropeptide Y expression in rat brain neuronal cultures.

Authors:  J J Poulakos; W J Millard; E M Meyer
Journal:  Brain Res Dev Brain Res       Date:  1993-07-16

7.  Use of adeno-associated virus as a mammalian DNA cloning vector: transduction of neomycin resistance into mammalian tissue culture cells.

Authors:  P L Hermonat; N Muzyczka
Journal:  Proc Natl Acad Sci U S A       Date:  1984-10       Impact factor: 11.205

8.  Partial processing of the neuropeptide Y precursor in transfected CHO cells.

Authors:  B S Wulff; M M O'Hare; E Boel; L E Theill; T W Schwartz
Journal:  FEBS Lett       Date:  1990-02-12       Impact factor: 4.124

9.  Evaluation of reconstituted Sendai virus envelopes as intra-articular drug vectors: effects on normal and experimentally arthritic rabbit knee joints.

Authors:  R T Earl; I M Hunneyball; E E Billett; R J Mayer
Journal:  J Pharm Pharmacol       Date:  1988-03       Impact factor: 3.765

10.  Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by non-homologous recombination.

Authors:  R M Kotin; R M Linden; K I Berns
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

View more
  1 in total

Review 1.  Designer gene delivery vectors: molecular engineering and evolution of adeno-associated viral vectors for enhanced gene transfer.

Authors:  Inchan Kwon; David V Schaffer
Journal:  Pharm Res       Date:  2007-09-01       Impact factor: 4.200

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.